190 related articles for article (PubMed ID: 21052789)
1. Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173.
Kong L; Deng Z; Shen H; Zhang Y
Mol Cell Biochem; 2011 Feb; 348(1-2):11-9. PubMed ID: 21052789
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells.
Kong L; Deng Z; Zhao Y; Wang Y; Sarkar FH; Zhang Y
Med Oncol; 2011 Dec; 28(4):1495-506. PubMed ID: 20532678
[TBL] [Abstract][Full Text] [Related]
3. Knockout of ATG5 leads to malignant cell transformation and resistance to Src family kinase inhibitor PP2.
Hwang SH; Han BI; Lee M
J Cell Physiol; 2018 Jan; 233(1):506-515. PubMed ID: 28294316
[TBL] [Abstract][Full Text] [Related]
4. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
[TBL] [Abstract][Full Text] [Related]
5. SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2832-9. PubMed ID: 16799022
[TBL] [Abstract][Full Text] [Related]
6. The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells.
Bartscht T; Lehnert H; Gieseler F; Ungefroren H
Cancer Chemother Pharmacol; 2012 Aug; 70(2):221-30. PubMed ID: 22699812
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Src on cervical cancer cells proliferation and apoptosis through ERK signal transduction pathway].
Song ZC; Ding L; Ren ZY; Sun XS; Yang Q; Wang L; Feng MJ; Liu CL; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1246-1251. PubMed ID: 28910941
[No Abstract] [Full Text] [Related]
8. Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation.
Nguyen AN; Jansson K; Sánchez G; Sharma M; Reif GA; Wallace DP; Blanco G
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F897-906. PubMed ID: 21697238
[TBL] [Abstract][Full Text] [Related]
9. Src inhibitor dasatinib inhibits growth of breast cancer cells by modulating EGFR signaling.
Nautiyal J; Majumder P; Patel BB; Lee FY; Majumdar AP
Cancer Lett; 2009 Oct; 283(2):143-51. PubMed ID: 19398150
[TBL] [Abstract][Full Text] [Related]
10. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
[TBL] [Abstract][Full Text] [Related]
11. Suppression of autophagy sensitizes multidrug resistant cells towards Src tyrosine kinase specific inhibitor PP2.
Ahn JH; Lee M
Cancer Lett; 2011 Nov; 310(2):188-97. PubMed ID: 21775053
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.
Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S
Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract][Full Text] [Related]
14. Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth.
Chen J; Kinoshita T; Sukbuntherng J; Chang BY; Elias L
Mol Cancer Ther; 2016 Dec; 15(12):2835-2844. PubMed ID: 27678331
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic regulation of swelling-activated Cl- current in rabbit ventricle by Src and EGFR protein tyrosine kinases.
Ren Z; Baumgarten CM
Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2628-36. PubMed ID: 15681694
[TBL] [Abstract][Full Text] [Related]
16. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases.
Tatton L; Morley GM; Chopra R; Khwaja A
J Biol Chem; 2003 Feb; 278(7):4847-53. PubMed ID: 12475982
[TBL] [Abstract][Full Text] [Related]
17. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic effect of PP2 a Src tyrosine kinase inhibitor, in murine B cell leukemia.
Lee M; Kim JY; Koh WS
J Cell Biochem; 2004 Oct; 93(3):629-38. PubMed ID: 15378599
[TBL] [Abstract][Full Text] [Related]
19. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
20. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
